A Bayesian approach to the survivor average causal effect in cluster-randomized crossover trials

Fuente: arXiv
Salvato in:
Dettagli Bibliografici
Autori principali: Isenberg, Dane, Harhay, Michael O., Forbes, Andrew B., Young, Paul J., Li, Fan, Mitra, Nandita
Natura: Preprint
Pubblicazione: 2025
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866908797116612608
author Isenberg, Dane
Harhay, Michael O.
Forbes, Andrew B.
Young, Paul J.
Li, Fan
Mitra, Nandita
author_facet Isenberg, Dane
Harhay, Michael O.
Forbes, Andrew B.
Young, Paul J.
Li, Fan
Mitra, Nandita
contents In cluster-randomized crossover (CRXO) trials, groups of individuals are randomly assigned to two or more sequences of alternating treatments. Since clusters serve as their own control, the CRXO design is typically more statistically efficient than the usual parallel-arm design. CRXO trials are increasingly popular in many areas of health research where the number of available clusters is limited. Further, in trials among severely ill patients, researchers often want to assess the effect of treatments on secondary non-terminal outcomes, but frequently in these studies, there are patients who do not survive to have these measurements fully recorded. In this paper, we provide a causal inference framework and treatment effect estimation methods for addressing truncation by death in the setting of CRXO trials. We target the survivor average causal effect (SACE) estimand, a well-defined subgroup treatment effect obtained via principal stratification. We propose novel structural and standard modeling assumptions that enable estimating the SACE within a Bayesian paradigm. We evaluate the small-sample performance of our proposed Bayesian approach for estimation of the SACE in CRXO trial settings via simulation studies. We apply our methods to a previously conducted two-period cross-sectional CRXO study examining the impact of proton pump inhibitors compared to histamine-2 receptor blockers on length of hospitalization among adults requiring invasive mechanical ventilation.
format Preprint
id arxiv_https___arxiv_org_abs_2505_21447
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle A Bayesian approach to the survivor average causal effect in cluster-randomized crossover trials
Isenberg, Dane
Harhay, Michael O.
Forbes, Andrew B.
Young, Paul J.
Li, Fan
Mitra, Nandita
Methodology
In cluster-randomized crossover (CRXO) trials, groups of individuals are randomly assigned to two or more sequences of alternating treatments. Since clusters serve as their own control, the CRXO design is typically more statistically efficient than the usual parallel-arm design. CRXO trials are increasingly popular in many areas of health research where the number of available clusters is limited. Further, in trials among severely ill patients, researchers often want to assess the effect of treatments on secondary non-terminal outcomes, but frequently in these studies, there are patients who do not survive to have these measurements fully recorded. In this paper, we provide a causal inference framework and treatment effect estimation methods for addressing truncation by death in the setting of CRXO trials. We target the survivor average causal effect (SACE) estimand, a well-defined subgroup treatment effect obtained via principal stratification. We propose novel structural and standard modeling assumptions that enable estimating the SACE within a Bayesian paradigm. We evaluate the small-sample performance of our proposed Bayesian approach for estimation of the SACE in CRXO trial settings via simulation studies. We apply our methods to a previously conducted two-period cross-sectional CRXO study examining the impact of proton pump inhibitors compared to histamine-2 receptor blockers on length of hospitalization among adults requiring invasive mechanical ventilation.
title A Bayesian approach to the survivor average causal effect in cluster-randomized crossover trials
topic Methodology
url https://arxiv.org/abs/2505.21447